From: Innate immunity and monocyte-macrophage activation in atherosclerosis
Human
Mouse
Classical/Inflammatory
CD14++ CD16- [195, 196]
(>90%)
Ly6C+ CCR2+ CD62L+ CX3CR1low [47, 59] (~50%)
Non-Classical/Resident
CD14+ CD16+ [195, 196]
(<10%)
Ly6C- CCR2- CD62L- CX3CR1high [47, 59] (~50%)